Pharmaceuticals & Biotech.    
SECTOR | 19 Jun 2021
Guinea declares end to latest Ebola outbreak that killed 12: WHO
Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 17 Jun, 2021.
Pharmaceuticals & Biotech.    
SECTOR | 17 Jun 2021
Prabhudas Lilladhar
Amongst top therapies anti-Infective, Cardiac, GI, anti-diabetic and VMN led IPM growth by 141.9%, 31%, 47.7%, 20.2% and 59.8% YoY in May-21. IPM growth in last few quarters remained below our expectations but with rise in Covid-19 cases since March'21 and limited lockdown restrictions, there was robust market share growth led by pick-up in overall volumes. We believe key reasons for such growth are (i) re-opening of doctor's clinics and noncovid hospital services supporting volume growth (ii) increase in patient footfall leading to new prescription (NRx), (iii) increased demand for Covid19 related precautionary products, (iv) sign of recovery in demand of acutetherapy products and (v) low base in Apr-May FY21 due to first wave. Amongst top therapies, anti-infective showed a sign of recovery and...
default
Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 17 Jun, 2021.
Pharmaceuticals & Biotech.    
SECTOR | 17 Jun 2021
Prabhudas Lilladhar
Amongst top therapies anti-Infective, Cardiac, GI, anti-diabetic and VMN led IPM growth by 141.9%, 31%, 47.7%, 20.2% and 59.8% YoY in May-21. IPM growth in last few quarters remained below our expectations but with rise in Covid-19 cases since March'21 and limited lockdown restrictions, there was robust market share growth led by pick-up in overall volumes. We believe key reasons for such growth are (i) re-opening of doctor's clinics and noncovid hospital services supporting volume growth (ii) increase in patient footfall leading to new prescription (NRx), (iii) increased demand for Covid19 related precautionary products, (iv) sign of recovery in demand of acutetherapy products and (v) low base in Apr-May FY21 due to first wave. Amongst top therapies, anti-infective showed a sign of recovery and...
Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 17 Jun, 2021.
Pharmaceuticals & Biotech.    
SECTOR | 09 Jun 2021
Govt allocates 170,000 vials of Amphotericin-B to states, UTs: Gowda
Govt allocates 170,000 vials of Amphotericin-B to states, UTs: Gowda
Business Standard
The government has allocated an additional 1.7 lakh vials of Amphotericin-B drug, used to treat black fungus infection, to states and union territories, Union Minister Sadananda Gowda said on Wednesday. "Ensuring adequate availability and smooth supply of #Amphotericin-B across the country, additional 1,70,000 vials of the drug have been allocated to all the States/UTs & Central Institutions today," the chemicals and fertilisers minister tweeted. Gowda added that an additional 15,520 vials of the critical drug have been allocated to Karnataka. "So far, a total of 40,470 vials of the drug have been allocated to the state including today's allocation for timely treatment of patients," he said. Amphotericin-B is used to treat Mucormycosis, also known as black fungus, which damages the nose, eyes, sinuses, and sometimes even the brain. Mucormycosis can be life-threatening in diabetic or severely immuno-compromised individuals such as cancer patients or people with HIV/AIDS. The...
Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 17 Jun, 2021.
Pharmaceuticals & Biotech.    
SECTOR | 07 Jun 2021
Drug firm Lupin gets US FDA approval to market generic HIV drug
Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 17 Jun, 2021.
Pharmaceuticals & Biotech.    
SECTOR | 06 Jun 2021
Coronavirus mutates over 30 times in HIV positive woman with COVID-19 infection
Coronavirus mutates over 30 times in HIV positive woman with COVID-19 infection
Business Today
After the woman contracted the COVID-19 infection in September last year, the virus gathered 13 mutations to spike protein and 19 other genetic shifts that might change the behaviour of the virus
Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 17 Jun, 2021.
Pharmaceuticals & Biotech.    
SECTOR | 04 Jun 2021
Ending HIV/AIDS epidemic by 2030 may be achievable, says Dr. Anthony Fauci
Ending HIV/AIDS epidemic by 2030 may be achievable, says Dr. Anthony Fauci
Moneycontrol
Even though tackling it has been sidetracked due to COVID-19, HIV/AIDS is still one of the most important things, US NIAID Director Dr. Anthony Fauci said.
Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 17 Jun, 2021.
Pharmaceuticals & Biotech.    
SECTOR | 03 Jun 2021
Romania launches drive to vaccinate 12-15-year-olds against coronavirus
Romania launches drive to vaccinate 12-15-year-olds against coronavirus
Business Standard
Romania started administering Covid-19 vaccines to young teenagers aged 12 to 15, after the European Medicines Agency approved use of the Pfizer jab last week for that age group
Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 17 Jun, 2021.
Pharmaceuticals & Biotech.    
SECTOR | 29 May 2021
EU clears Pfizer-BioNTech covid-19 vaccine for 12 to 15-year-olds
EU clears Pfizer-BioNTech covid-19 vaccine for 12 to 15-year-olds
livemint
The decision comes after European Medicines Agency (EMA) backed the use of the vaccine in 12- to 15-year olds earlier in the day.
Pharmaceuticals & Biotech.    
SECTOR | 26 May 2021
Belgium suspends Johnson & Johnson vaccine for under 41s after death
Belgium suspends Johnson & Johnson vaccine for under 41s after death
Business Standard
Belgium on Wednesday suspended the use of the Johnson & Johnson COVID-19 vaccine for people under age 41 following the death of a person who had received the shot. The government said in a statement it was asking for urgent advice from the European Medicines Agency, the European Union's drug regulator, before it would consider lifting the suspension. It added that the impact on the national vaccination drive would be very limited. Belgium was using the Johnson & Johnson vaccine for elderly with reduced mobility and the homeless since it only takes one shot to be protected. Those shots will be continued. It said it took the action after a single case where there was serious side effects after administering the Janssen vaccine, using the local name for the Johnson & Johnson shot. It said a woman was vaccinated through her foreign employer outside the Belgian system and had died in Belgium last week after developing serious thrombosis and reduced blood platelets. It didn't...
Prabhudas Lilladhar released a Sector Update report for Pharmaceuticals & Biotech. on 17 Jun, 2021.